US Stock MarketDetailed Quotes

AQST Aquestive Therapeutics

Watchlist
  • 3.210
  • +0.100+3.22%
Close Mar 21 16:00 ET
  • 3.260
  • +0.050+1.56%
Post 19:58 ET
317.38MMarket Cap-6.29P/E (TTM)

Aquestive Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-460.49%-35.76M
-31.33%-6.49M
-405.96%-11.88M
11.39%-7.01M
-217.79%-10.38M
35.02%-6.38M
-158.71%-4.94M
-183.59%-2.35M
-20.50%-7.91M
160.88%8.82M
Net income from continuing operations
-460.83%-44.14M
-110.27%-17.06M
-465.55%-11.51M
52.61%-2.75M
-259.00%-12.83M
85.54%-7.87M
34.33%-8.11M
83.77%-2.04M
64.47%-5.79M
161.03%8.07M
Operating gains losses
----
----
----
----
----
--1.03M
----
----
----
----
Depreciation and amortization
-46.62%718K
-68.59%147K
-39.54%159K
-29.07%205K
-36.31%207K
-43.65%1.35M
17.88%468K
-55.87%263K
-56.67%289K
-55.30%325K
Other non cash items
494.91%10.52M
49.13%2.73M
2,996.59%2.73M
4,430.77%2.36M
1,425.98%2.71M
-69.76%1.77M
3,492.59%1.83M
-96.05%88K
-97.25%52K
-111.49%-204K
Change In working capital
-86.43%-9.96M
580.36%5.28M
-236.26%-4.83M
-170.85%-8.36M
-823.67%-2.05M
-116.70%-5.34M
-105.58%-1.1M
-111.99%-1.44M
-162.24%-3.09M
106.05%283K
-Change in receivables
135.60%1.09M
2,132.69%2.32M
-339.46%-3.71M
193.15%2.34M
106.63%147K
-141.80%-3.07M
-98.29%104K
-81.10%1.55M
-444.44%-2.51M
71.13%-2.22M
-Change in inventory
173.31%725K
215.16%977K
95.13%-55K
-25.51%768K
19.65%-965K
43.26%-989K
-67.16%310K
34.25%-1.13M
372.03%1.03M
-103.21%-1.2M
-Change in prepaid assets
-117.29%-223K
-1,889.04%-1.31M
-32.44%-788K
5.83%2.12M
-29.74%-253K
-7.79%1.29M
110.25%73K
-77.61%-595K
-25.00%2.01M
15.22%-195K
-Change in payables and accrued expense
136.49%1.29M
3,215.79%3.55M
153.44%1.21M
1.20%-2.89M
39.78%-589K
-4,677.03%-3.54M
90.09%-114K
-81.01%479K
-225.19%-2.92M
74.13%-978K
-Change in other working capital
-1,429.50%-12.84M
82.28%-261K
14.57%-1.49M
-1,446.97%-10.71M
-107.96%-388K
-96.14%966K
-110.13%-1.47M
-152.71%-1.74M
-73.00%-692K
-35.89%4.87M
Cash from discontinued investing activities
Operating cash flow
-460.49%-35.76M
-31.30%-6.49M
-406.18%-11.88M
11.39%-7.01M
-217.79%-10.38M
35.02%-6.38M
-158.72%-4.94M
-183.55%-2.35M
-20.50%-7.91M
160.88%8.82M
Investing cash flow
Cash flow from continuing investing activities
84.02%-159K
6.25%-15K
47.02%-80K
95.76%-35K
-1,350.00%-29K
60.58%-995K
38.46%-16K
91.21%-151K
-22.01%-826K
98.08%-2K
Capital expenditure reported
84.02%-159K
6.25%-15K
47.02%-80K
95.76%-35K
-1,350.00%-29K
2.83%-995K
38.46%-16K
30.41%-151K
-22.01%-826K
98.08%-2K
Cash from discontinued investing activities
Investing cash flow
84.02%-159K
6.25%-15K
47.02%-80K
95.76%-35K
-1,350.00%-29K
60.58%-995K
38.46%-16K
91.21%-151K
-22.01%-826K
98.08%-2K
Financing cash flow
Cash flow from continuing financing activities
2,003.47%83.59M
-95.99%157K
-100.34%-17K
-60.09%1.71M
988.01%81.74M
-65.72%3.97M
1,572.22%3.91M
3,707.97%4.98M
-57.96%4.29M
-809.17%-9.21M
Net issuance payments of debt
99.90%-23K
99.95%-5K
-100.78%-8K
99.89%-5K
99.94%-5K
-1,010.47%-22.49M
-390.81%-9.94M
51.41%1.02M
-564.30%-4.48M
---9.09M
Net common stock issuance
839.82%83.76M
-100.93%-34K
--0
-59.49%1.69M
8,862.88%82.1M
-34.40%8.91M
-46.22%3.64M
-66.18%184K
-16.18%4.17M
-29.43%916K
Proceeds from stock option exercised by employees
-88.45%964K
876.92%202K
-95.98%193K
-99.16%30K
--539K
24,450.00%8.35M
99.56%-26K
120,100.00%4.8M
--3.57M
--0
Net other financing activities
-112.02%-1.11M
-100.06%-6K
80.33%-202K
-100.49%-5K
13.72%-893K
306,833.33%9.2M
658.52%10.24M
---1.03M
--1.02M
---1.04M
Cash from discontinued financing activities
Financing cash flow
2,003.47%83.59M
-95.99%157K
-100.34%-17K
-60.09%1.71M
988.01%81.74M
-65.72%3.97M
1,572.22%3.91M
3,707.97%4.98M
-57.96%4.29M
-809.17%-9.21M
Net cash flow
Beginning cash position
-12.47%23.87M
212.61%77.89M
300.56%89.87M
254.14%95.2M
-12.47%23.87M
-2.68%27.27M
33.61%24.92M
26.79%22.44M
82.42%26.88M
-2.68%27.27M
Current changes in cash
1,501.76%47.67M
-507.37%-6.35M
-582.75%-11.98M
-19.88%-5.33M
18,342.46%71.33M
-352.86%-3.4M
-112.12%-1.05M
160.06%2.48M
-250.25%-4.45M
97.06%-391K
End cash Position
199.71%71.55M
199.71%71.55M
212.61%77.89M
300.56%89.87M
254.14%95.2M
-12.47%23.87M
-12.47%23.87M
33.61%24.92M
26.79%22.44M
82.42%26.88M
Free cash flow
-387.02%-35.92M
-31.18%-6.5M
-378.78%-11.96M
19.37%-7.04M
-218.14%-10.41M
40.25%-7.38M
-159.09%-4.96M
-328.75%-2.5M
-20.64%-8.73M
160.43%8.81M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -460.49%-35.76M-31.33%-6.49M-405.96%-11.88M11.39%-7.01M-217.79%-10.38M35.02%-6.38M-158.71%-4.94M-183.59%-2.35M-20.50%-7.91M160.88%8.82M
Net income from continuing operations -460.83%-44.14M-110.27%-17.06M-465.55%-11.51M52.61%-2.75M-259.00%-12.83M85.54%-7.87M34.33%-8.11M83.77%-2.04M64.47%-5.79M161.03%8.07M
Operating gains losses ----------------------1.03M----------------
Depreciation and amortization -46.62%718K-68.59%147K-39.54%159K-29.07%205K-36.31%207K-43.65%1.35M17.88%468K-55.87%263K-56.67%289K-55.30%325K
Other non cash items 494.91%10.52M49.13%2.73M2,996.59%2.73M4,430.77%2.36M1,425.98%2.71M-69.76%1.77M3,492.59%1.83M-96.05%88K-97.25%52K-111.49%-204K
Change In working capital -86.43%-9.96M580.36%5.28M-236.26%-4.83M-170.85%-8.36M-823.67%-2.05M-116.70%-5.34M-105.58%-1.1M-111.99%-1.44M-162.24%-3.09M106.05%283K
-Change in receivables 135.60%1.09M2,132.69%2.32M-339.46%-3.71M193.15%2.34M106.63%147K-141.80%-3.07M-98.29%104K-81.10%1.55M-444.44%-2.51M71.13%-2.22M
-Change in inventory 173.31%725K215.16%977K95.13%-55K-25.51%768K19.65%-965K43.26%-989K-67.16%310K34.25%-1.13M372.03%1.03M-103.21%-1.2M
-Change in prepaid assets -117.29%-223K-1,889.04%-1.31M-32.44%-788K5.83%2.12M-29.74%-253K-7.79%1.29M110.25%73K-77.61%-595K-25.00%2.01M15.22%-195K
-Change in payables and accrued expense 136.49%1.29M3,215.79%3.55M153.44%1.21M1.20%-2.89M39.78%-589K-4,677.03%-3.54M90.09%-114K-81.01%479K-225.19%-2.92M74.13%-978K
-Change in other working capital -1,429.50%-12.84M82.28%-261K14.57%-1.49M-1,446.97%-10.71M-107.96%-388K-96.14%966K-110.13%-1.47M-152.71%-1.74M-73.00%-692K-35.89%4.87M
Cash from discontinued investing activities
Operating cash flow -460.49%-35.76M-31.30%-6.49M-406.18%-11.88M11.39%-7.01M-217.79%-10.38M35.02%-6.38M-158.72%-4.94M-183.55%-2.35M-20.50%-7.91M160.88%8.82M
Investing cash flow
Cash flow from continuing investing activities 84.02%-159K6.25%-15K47.02%-80K95.76%-35K-1,350.00%-29K60.58%-995K38.46%-16K91.21%-151K-22.01%-826K98.08%-2K
Capital expenditure reported 84.02%-159K6.25%-15K47.02%-80K95.76%-35K-1,350.00%-29K2.83%-995K38.46%-16K30.41%-151K-22.01%-826K98.08%-2K
Cash from discontinued investing activities
Investing cash flow 84.02%-159K6.25%-15K47.02%-80K95.76%-35K-1,350.00%-29K60.58%-995K38.46%-16K91.21%-151K-22.01%-826K98.08%-2K
Financing cash flow
Cash flow from continuing financing activities 2,003.47%83.59M-95.99%157K-100.34%-17K-60.09%1.71M988.01%81.74M-65.72%3.97M1,572.22%3.91M3,707.97%4.98M-57.96%4.29M-809.17%-9.21M
Net issuance payments of debt 99.90%-23K99.95%-5K-100.78%-8K99.89%-5K99.94%-5K-1,010.47%-22.49M-390.81%-9.94M51.41%1.02M-564.30%-4.48M---9.09M
Net common stock issuance 839.82%83.76M-100.93%-34K--0-59.49%1.69M8,862.88%82.1M-34.40%8.91M-46.22%3.64M-66.18%184K-16.18%4.17M-29.43%916K
Proceeds from stock option exercised by employees -88.45%964K876.92%202K-95.98%193K-99.16%30K--539K24,450.00%8.35M99.56%-26K120,100.00%4.8M--3.57M--0
Net other financing activities -112.02%-1.11M-100.06%-6K80.33%-202K-100.49%-5K13.72%-893K306,833.33%9.2M658.52%10.24M---1.03M--1.02M---1.04M
Cash from discontinued financing activities
Financing cash flow 2,003.47%83.59M-95.99%157K-100.34%-17K-60.09%1.71M988.01%81.74M-65.72%3.97M1,572.22%3.91M3,707.97%4.98M-57.96%4.29M-809.17%-9.21M
Net cash flow
Beginning cash position -12.47%23.87M212.61%77.89M300.56%89.87M254.14%95.2M-12.47%23.87M-2.68%27.27M33.61%24.92M26.79%22.44M82.42%26.88M-2.68%27.27M
Current changes in cash 1,501.76%47.67M-507.37%-6.35M-582.75%-11.98M-19.88%-5.33M18,342.46%71.33M-352.86%-3.4M-112.12%-1.05M160.06%2.48M-250.25%-4.45M97.06%-391K
End cash Position 199.71%71.55M199.71%71.55M212.61%77.89M300.56%89.87M254.14%95.2M-12.47%23.87M-12.47%23.87M33.61%24.92M26.79%22.44M82.42%26.88M
Free cash flow -387.02%-35.92M-31.18%-6.5M-378.78%-11.96M19.37%-7.04M-218.14%-10.41M40.25%-7.38M-159.09%-4.96M-328.75%-2.5M-20.64%-8.73M160.43%8.81M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+5.27%
Apple
AAPL
+1.95%
Meta Platforms
META
+1.75%
Microsoft
MSFT
+1.14%
Petroleo Brasileiro SA Petrobras
PBR
+0.93%

Unlock the Full List